Schonfeld Strategic Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,840
| Closed | -$50K | – | 2055 |
|
|
2024
Q2 | $50K | Buy |
+3,840
| New | +$50K | ﹤0.01% | 1793 |
|
|
2022
Q4 | – | Sell |
-1,257
| Closed | -$102K | – | 2719 |
|
|
2022
Q3 | $102K | Buy |
+1,257
| New | +$102K | ﹤0.01% | 2485 |
|
|
2021
Q4 | – | Sell |
-1,174
| Closed | -$102K | – | 2172 |
|
|
2021
Q3 | $102K | Buy |
+1,174
| New | +$102K | ﹤0.01% | 1834 |
|
|
2021
Q2 | – | Sell |
-11,914
| Closed | -$1.88M | – | 2071 |
|
|
2021
Q1 | $1.88M | Buy |
+11,914
| New | +$1.88M | 0.02% | 649 |
|
|
2020
Q3 | – | Sell |
-1,423
| Closed | -$405K | – | 1466 |
|
|
2020
Q2 | $405K | Buy |
1,423
+421
| +42% | +$120K | 0.01% | 841 |
|
|
2020
Q1 | $289K | Sell |
1,002
-4,802
| -83% | -$1.39M | 0.02% | 771 |
|
|
2019
Q4 | $1.67M | Sell |
5,804
-13,203
| -69% | -$3.8M | 0.04% | 374 |
|
|
2019
Q3 | $2.74M | Buy |
+19,007
| New | +$2.74M | 0.08% | 255 |
|
|
2019
Q2 | – | Sell |
-6,987
| Closed | -$612K | – | 1120 |
|
|
2019
Q1 | $612K | Sell |
6,987
-1,200
| -15% | -$105K | 0.02% | 637 |
|
|
2018
Q4 | $1.15M | Sell |
8,187
-19,686
| -71% | -$2.77M | 0.04% | 444 |
|
|
2018
Q3 | $7.12M | Buy |
27,873
+166
| +0.6% | +$42.4K | 0.32% | 82 |
|
|
2018
Q2 | $7.06M | Buy |
27,707
+3,514
| +15% | +$896K | 0.38% | 69 |
|
|
2018
Q1 | $4.87M | Buy |
24,193
+7,526
| +45% | +$1.51M | 0.37% | 70 |
|
|
2017
Q4 | $2.4M | Hold |
16,667
| – | – | 0.2% | 145 |
|
|
2017
Q3 | $2.75M | Sell |
16,667
-5,000
| -23% | -$823K | 0.25% | 124 |
|
|
2017
Q2 | $2.94M | Sell |
21,667
-1,000
| -4% | -$136K | 0.3% | 92 |
|
|
2017
Q1 | $4.37M | Buy |
+22,667
| New | +$4.37M | 0.44% | 56 |
|